by Erik Valent | Apr 6, 2021 | Uncategorized
Multiple myeloma is caused by the abnormal proliferation of plasma cells which produce antibodies as part of the organism’s natural defence. Although treatment options have expanded over the years, it remains incurable, and patients often receive multiple treatments...
by Erik Valent | Jan 6, 2021 | Uncategorized
Summary of the context and overall objectives of the project The Horizon 2020 MMpredict initiative was started on November 1st 2016 and included the following consortium partners: SkylineDx, the Department of Haematology of the Erasmus University Medical Centre...
by Erik Valent | Nov 2, 2020 | Uncategorized
After more than 4 years of research, the H2020-funded MMpredict project is successfully implemented and officially concluded as of November 1st, 2020. However, research in the field of multiple myeloma should never stop. Therefore we’ll host a subsequent...
by Erik Valent | Aug 26, 2020 | Uncategorized
The European Commission has validated the amendment request of the MMpredict consortium to extend the project duration with 6 month to 31th of October 2020. Due to the COVID-19 outbreak the finalization of the project was hampered since all planned interactions and...
by Erik Valent | Aug 26, 2020 | Uncategorized
Watch the interesting webinar on personalized medicine organized by Myeloma Patients Europe (MPE). In this webinar, Dr. Francesca Bonello from the Università degli Studi di Torino, Turin, Italy – provided examples of the individualized therapy options including future...
